ReviewRomanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
Biomarkers in schizophrenia - past, present and future.
Review in Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- [Breath metabolomic characteristics of schizophrenia and their potential for auxiliary diagnosis].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026Article
- Whole transcriptome sequencing to uncover CircRNA expression patterns linked to schizophrenia pathogenesis.European journal of medical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schizophrenia is a complex and debilitating neuropsychiatric syndrome. Although research into the etiology of this pathology has advanced considerably, consistent results are still awaited. The discovery of biomarkers that could underlie diagnosis and treatment could revolutionize the management of this pathology, and approaching biomarkers from an evolutionary perspective, along with the multitude of existing and future studies, can provide important information. The complexity of this multifactorial pathology requires its approach from an integrated and multidisciplinary perspective, which considers research on neurodevelopment, genetics, imaging and, last but not least, neurobiological research. The present material aims to bring to light a series of recent research, as well as the approach to this pathology from an evolutionary perspective of neurodevelopment, in the hope that it will constitute an attractive point of view that could imagine new ways of approaching this pathology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.